CA-170 is a small-molecule, orally active dual inhibitor of the immune checkpoints VISTA and PD-L1, used as a research reagent to modulate immune responses in preclinical immunology and oncology studies. It has been shown to restore T-cell proliferation and effector functions inhibited by PD-L1 and VISTA and is supplied as a powder for laboratory use.
- Oral small-molecule dual inhibitor of VISTA and PD-L1.
- Restores T-cell proliferation and effector function in inhibited systems.
- Suitable for in vitro and in vivo preclinical research applications.
- High purity by HPLC (approximately 99.4%).
- Molecular weight 360.32 g·mol⁻¹; formula C12H20N6O7.
- Supplied as a powder with recommended cold-storage conditions.